- 2024-04-30
-
NOF CORPORATION and Phosphorex Collaborate to Supply Lipid Nanoparticle Formulations Using NOF’s Proprietary Ionizable Lipid, COATSOME® SS Series
Tokyo, Japan, Hopkinton, MA – April 30, 2024 – NOF CORPORATION announced today a collaboration with Phos […]
- 2024-04-23
-
NOF to Exhibit at ASGCT 27th Annual Meeting from May 7 to 11, Scientist to Deliver Presentation on May 8
NOF CORPORATION is pleased to announce its participation in the upcoming American Society of Gene and Cell The […]
- 2024-04-09
-
NOF to Exhibit and Present at TIDES USA 2024 (May 14 – 17)
NOF CORPORATION is pleased to announce its participation in the upcoming TIDES: Oligonucleotide and Peptide Th […]
- 2024-04-01
-
NOF to Exhibit at Formulation & Delivery 2024 on 25 and 26 Apr
NOF CORPORATION is pleased to announce its participation in the upcoming Formulation & Delivery 2024, whic […]
- 2024-03-21
-
Notice of Website Maintenance (3/22)
Due to system maintenance, this site will be temporarily unavailable on Fri, March 22, 2:00PM – 3:00PM ( […]
- 2024-03-13
-
NOF to Exhibit and Present at 3rd Annual LNP Formulation & Process Development Summit (April 30 – May 1)
NOF CORPORATION is pleased to announce its participation in the upcoming 3rd Annual LNP Formulation & Proc […]
- 2024-01-26
-
Revisions to Privacy Policy
In accordance with the California Consumer Privacy Act, we have added Special Notice to California Residents t […]
- 2023-12-28
-
NOF Attends BIO Partnering at JPM Week 2024 from January 8 to 11
NOF CORPORATION is attending, from January 8th to 11th , the BIO Partnering at JPM Week 2024 at the San Franci […]
- 2023-12-15
-
NOF Exhibits at RNA Leaders Europe Congress 2024 on 13 and 14 Mar.
NOF CORPORATION is exhibiting at RNA Leaders Europe Congress 2024 to be held at Congress Center, Basel, Switze […]
- 2023-10-26
-
NOF Exhibits at Extracellular Vesicles & Nanoparticle-based Therapeutics Europe 2023 from Nov. 13 – Nov. 14
NOF CORPORATION is exhibiting at Extracellular Vesicles & Nanoparticle-based Therapeutics Europe 2023 to b […]
